|
| Volume 32(2); March 2021 |
| Editorials |
| |
jgo.2021.32.e35
Increased risk of herpes zoster in gynecological cancer patients receiving radiotherapy combined with chemotherapy: a need for paying attention to vaccines
Shin DH, Song KH. |
| |
jgo.2021.32.e36
How to start niraparib in real-world Asian ovarian cancer patients?
Hong SH. |
| |
jgo.2021.32.e34
Current status and future directions of ovarian cancer prognostic models
Kobayashi Y, Banno K, Aoki D. |
| |
jgo.2021.32.e33
Comments on: Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
Kwon JS. |
| |
jgo.2021.32.e39
Evaluating robotic surgical courses: structured training matters
Falconer H. |
| |
jgo.2021.32.e47
Post-LACC era: critical assessment not “all-or-none” is needed
Leitao MM, Kim SI, Kim JW. |
| |
jgo.2021.32.e38
Lumping and splitting: The need for precision medicine and “personomics” in endometrial cancer
Reyes-Baez FE, Garzon S, Mariani A. |
| |
jgo.2021.32.e50
Comments on: Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy
Shin HS. |
| Practice Guideline |
| |
jgo.2021.32.e49
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, Satoh T, Hirashima Y, Matsumura N, Yokoyama Y, Kawana K, Kyo S, Aoki D, Katabuchi H. |
| Original Articles |
| Cervix |
| |
jgo.2021.32.e15
Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy
Liu Y, Jiang P, Zhang H, Wang J. |
| |
jgo.2021.32.e17
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study
Li P, Chen L, Ni Y, Liu J, Li D, Guo J, Liu Z, Jin S, Xu Y, Li Z, Wang L, Bin X, Lang J, Liu P, Chen C. |
| Uterine Corpus |
| |
jgo.2021.32.e11
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer
Tortorella L, Restaino S, Zannoni GF, Vizzielli G, Chiantera V, Cappuccio S, Gioè A, La Fera E, Dinoi G, Angelico G, Scambia G, Fanfani F. |
| |
jgo.2021.32.e22
Recurrence risk factors in stage IA grade 1 endometrial cancer
Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, Kidd E. |
| Ovary |
| |
jgo.2021.32.e16
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer
Okamoto A, Kondo E, Nakamura T, Yanagida S, Hamanishi J, Harano K, Hasegawa K, Hirasawa T, Hori K, Komiyama S, Matsuura M, Nakai H, Nakamura H, Sakata J, Tabata T, Takehara K, Takekuma M, Yokoyama Y, Kase Y, Sumino S, Soeda J, Suri A, Aoki D, Sugiyama T. |
| |
jgo.2021.32.e18
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
Lu HY, Tai YJ, Chen YL, Chiang YC, Hsu HC, Cheng WF. |
| |
jgo.2021.32.e21
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
Takehara K, Matsumoto T, Hamanishi J, Hasegawa K, Matsuura M, Miura K, Nagao S, Nakai H, Tanaka N, Tokunaga H, Ushijima K, Watari H, Yokoyama Y, Kase Y, Sumino S, Suri A, Itamochi H, Takeshima N. |
| |
jgo.2021.32.e23
Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
Jung Y, Hur S, Liu J, Lee S, Kang BS, Kim M, Choi YJ. |
| |
jgo.2021.32.e27
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
Tan DS, Chan JJ, Hettle R, Ghosh W, Viswambaram A, Yu CC. |
| Education |
| |
jgo.2021.32.e26
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum
Boitano TK, Smith HJ, Cohen JG, Rossi EC, Kim KH. |
| Supportive Care |
| |
jgo.2021.32.e13
Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study
Lee PY, Lai JN, Chen SW, Lin YC, Chiu LT, Wei YT. |
| Clinical Trial Protocol |
| |
jgo.2021.32.e31
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
Lee YJ, Lim MC, Kim BG, Ngoi NY, Choi CH, Park SY, Tan DS, Go Y, Lee JY. |
| Review Article |
| |
jgo.2021.32.e25
Lymphadenectomy issues in endometrial cancer
Konno Y, Asano H, Shikama A, Aoki D, Tanikawa M, Oki A, Horie K, Mitsuhashi A, Kikuchi A, Tokunaga H, Terao Y, Satoh T, Ushijima K, Ishikawa M, Yaegashi N, Watari H. |
| Correspondence |
| |
jgo.2021.32.e24
Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study
Matsuo K, Nishio S, Matsuzaki S, Machida H, Mikami M. |
| Society News |
| |
jgo.2021.32.e41
Reviewer recognition in 2020
Journal of Gynecologic Oncology (JGO) Editorial Office. |
| |
|
| |
|
| |
|
|
|
